Literature DB >> 20211308

Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents.

Kyung Woo Park1, Chi-Hoon Kim, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim.   

Abstract

BACKGROUND: Recent studies have suggested the possibility of late catch-up after drug-eluting stent implantation. There are limited data on whether late catch-up exists in sirolimus-eluting stents (SESs) and paclitaxel-eluting stents (PESs).
METHODS: Consecutive patients were routinely recommended 2 serial angiographic follow-ups (at 6-9 and 18-24 months post-percutaneous coronary intervention). A serial quantitative coronary angiographic analysis was performed in lesions not receiving target lesion revascularization at first follow-up. Early luminal loss (LL) was defined as the difference in minimal luminal diameter between the first angiographic follow-up and immediate post-percutaneous coronary intervention, and delayed LL was defined as the difference in minimal luminal diameter between the second and first angiographic follow-up.
RESULTS: Four hundred twelve lesions in the main cohort (PES 128, SES 284) and 47 lesions in the secondary hybrid cohort (PES 23, SES 24), which received serial angiographic follow-ups without target lesion revascularization, were included. In the main cohort, early LL was higher in PES compared with SES (0.56 vs 0.20 mm, P < .01), whereas delayed LL occurring after the first angiographic follow-up was higher in SES (0.10 vs 0.28 mm, P < .01), suggesting more prominent late catch-up in SES. Early LL showed better correlation with total LL (correlation coefficient 0.82 vs 0.30) in PES, whereas delayed LL showed better correlation with total LL (correlation coefficient 0.42 vs 0.91) in SES. Such observations were reproducible in the hybrid cohort, where both SES and PES were implanted at index procedure.
CONCLUSION: Late catch-up occurs in both PES and SES with greater delayed late loss in SES. Our data suggest that the process of neointima formation after SES and PES implantation may follow a slightly different timeline.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211308     DOI: 10.1016/j.ahj.2010.01.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions.

Authors:  Saami K Yazdani; Andrew Farb; Masataka Nakano; Marc Vorpahl; Elena Ladich; Aloke V Finn; Frank D Kolodgie; Renu Virmani
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

2.  Tissue characteristics of neointima in late restenosis: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Authors:  Hirohiko Ando; Akihiro Suzuki; Shinichiro Sakurai; Soichiro Kumagai; Akiyoshi Kurita; Katsuhisa Waseda; Hiroaki Takashima; Tetsuya Amano
Journal:  Heart Vessels       Date:  2016-10-11       Impact factor: 2.037

3.  Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study.

Authors:  Norihiro Kobayashi; Yoshiaki Ito; Keisuke Hirano; Masahiro Yamawaki; Motoharu Araki; Tsuyoshi Sakai; Hideyuki Takimura; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Takuro Takama; Hiroya Takafuji; Takashi Maruyama; Yohsuke Honda; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Toshiya Muramatsu
Journal:  Heart Vessels       Date:  2016-03-02       Impact factor: 2.037

Review 4.  Choosing the right coronary stent in the modern era.

Authors:  Bora Toklu; Sripal Bangalore
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

5.  Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.

Authors:  Rodolfo Staico; Marco A Costa; Daniel Chamié; Hiram Bezerra; Luciana V Armaganijan; Ricardo A Costa; José Ribamar Costa; Dimytri Siqueira; Marinella Centemero; Áurea Chaves; Luiz Fernando Tanajura; Alexandre Abizaid; Fausto Feres; J Eduardo M R Sousa; Amanda G M R Sousa
Journal:  Int J Cardiovasc Imaging       Date:  2013-03-03       Impact factor: 2.357

6.  CT Imaging of Coronary Stents: Past, Present, and Future.

Authors:  Andreas H Mahnken
Journal:  ISRN Cardiol       Date:  2012-09-11

7.  Effect of final kissing balloon dilatation after one-stent technique at left-main bifurcation: a single center data.

Authors:  Zhan Gao; Bo Xu; Yue-Jin Yang; Shu-Bin Qiao; Yong-Jian Wu; Tao Chen; Liang Xu; Jin-Qing Yuan; Jue Chen; Xue-Wen Qin; Min Yao; Hai-Bo Liu; Shi-Jie You; Ye-Lin Zhao; Hong-Bing Yan; Ji-Lin Chen; Run-Lin Gao
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

8.  Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year.

Authors:  Kyeong Ho Yun; Jum Suk Ko; Sang Jae Rhee; Eun Mi Lee; Nam Jin Yoo; Nam-Ho Kim; Seok Kyu Oh; Jin-Won Jeong
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

9.  Seven-year clinical outcomes of sirolimus-eluting stent versus bare-metal stent: a matched analysis from a real world, single center registry.

Authors:  Ung Kim; Jong-Seon Park; Sang-Hee Lee; Dong-Gu Shin; Young-Jo Kim
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

10.  Lesion length impacts long term outcomes of drug-eluting stents and bare metal stents differently.

Authors:  Shang-Hung Chang; Chun-Chi Chen; Ming-Jer Hsieh; Chao-Yung Wang; Cheng-Hung Lee; I-Chang Hsieh
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.